FIVE vs IONS · P/E 28, rev $1.39B vs rev $226.6M
Five Below Inc (FIVE) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
Five Below Inc (FIVE) is a specialty retail company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported FIVE revenue for 2025-02-01 was $1.39B. Net income was $187.5M. Revenue was up 64.9% from 2024-11-02 to 2025-02-01. FIVE currently screens at market cap $7.30B and trailing P/E 27.7.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
FIVE currently screens at market cap $7.30B and trailing P/E 27.7. IONS currently screens at market cap $12.28B.
Not investment advice. Open the FIVE and IONS stock pages for the full models.
Not investment advice.